Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Vicent, Bodí"'
Autor:
Agustín Fernández-Cisnal, Beatriz Silla, José María Ramón, Ernesto Valero, Sergio García-Blas, Julio Núñez, Vicent Bodí, Juan Sanchis, Gema Miñana,
Publikováno v:
REC: Interventional Cardiology, Vol 5, Iss 3, Pp 203-209 (2023)
RESUMEN Introducción y objetivos: Las intervenciones coronarias percutáneas (ICP) sobre oclusiones totales crónicas (OTC) son procedimientos largos en los que muchos pacientes sufren ansiedad y dolor. La realidad virtual ha demostrado reducir el d
Externí odkaz:
https://doaj.org/article/51b54ae6e3a44fccb9bf51d6551ce826
Autor:
Agustín Fernández-Cisnal, Beatriz Silla, José María Ramón, Ernesto Valero, Sergio García-Blas, Julio Núñez, Vicent Bodí, Juan Sanchis, Gema Miñana
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 5, Iss 3, Pp 203-209 (2023)
ABSTRACT Introduction and objectives: Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) are long procedures where many patients suffer moderate-to-high level anxiety and pain. Virtual reality (VR) has proven capable of reduc
Externí odkaz:
https://doaj.org/article/516be09f22db401698b01b3178cd261a
Autor:
Julio Núñez, Miguel Lorenzo, Gema Miñana, Patricia Palau, Jose V. Monmeneu, Maria P. López‐Lereu, Jose Gavara, Víctor Marcos‐Garcés, Cesar Rios‐Navarro, Nerea Pérez, Elena deDios, Eduardo Núñez, Juan Sanchis, Francisco J. Chorro, Antoni Bayés‐Genís, Vicent Bodí
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 264-273 (2023)
Abstract Aims Traditional adverse events in chronic coronary syndrome (CCS) include atherothrombotic events but usually exclude heart failure (HF). Data are scarce about how new‐onset HF modifies mortality risk. We aimed to determine the incidence
Externí odkaz:
https://doaj.org/article/5d43c04b25724b559c44b0fb12964ce4
Autor:
Carmen Mora-Fernández, Adora Pérez, Anna Mollar, Patricia Palau, Martina Amiguet, Rafael de la Espriella, Juan Sanchis, Jose Luis Górriz, María José Soler, Juan F. Navarro-González, Julio Núñez, DAPA-VO2 Investigators, Eloy Domínguez, Clara Sastre, Julia Seller, Jose Manuel Garcia Pinilla, Ainoha Larumbe, Alfonso Valle, Juan Jose Gómez Doblas, Gema Miñana, Ainhoa Robles Mezcua, Enrique Santas, Vicent Bodí, Domingo Pascual-Figal, Antonio Baýes-Genís, Jose Civera, Adriana Conesa, Rim Zakarne, Clara Jiménez Rubio, Alejandro I. Pérez Cabeza, Arancha Díaz Expósito, José David Martínez Carmona, Manuel Luna Morales, Francisco J. Zafra Sánchez, Ángel Montiel Trujillo, Herminio Morillas Climent
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
The klotho and fibroblast growth factor 23 (FGF-23) pathway is implicated in cardiovascular pathophysiology. This substudy aimed to assess the changes in klotho and FGF-23 levels 1-month after dapagliflozin in patients with stable heart failure and r
Externí odkaz:
https://doaj.org/article/facd3ac757c94cf687cc507deadc3111
Autor:
Anna Mollar, Vannina G. Marrachelli, Eduardo Núñez, Daniel Monleon, Vicent Bodí, Juan Sanchis, David Navarro, Julio Núñez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract In patients with heart failure (HF), the exhaled concentrations of hydrogen after a breath test—a non-invasive assessment of small intestinal overgrowth- has been related to HF severity and higher risk of adverse outcomes. Indeed, two inte
Externí odkaz:
https://doaj.org/article/cce0c779f69146fe855347fb475f4017
Autor:
Irene del Canto, Enrique Santas, Ingrid Cardells, Gema Miñana, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Raquel López‐Vilella, Luis Almenar, Vicent Bodí, Maria P. López‐Lereu, Jose V. Monmeneu, Juan Sanchis, David Moratal, Alicia M. Maceira, Rafael de la Espriella, Francisco J. Chorro, Antoni Bayés‐Genís, Julio Núñez
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 7 (2022)
Background The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial‐IRO
Externí odkaz:
https://doaj.org/article/a103d0209d6b45ef92b7486fbe443fbb
Autor:
Vicente Bertomeu‐Gonzalez, Lorenzo Fácila, Patricia Palau, Gema Miñana, Gonzalo Núñez, Rafael de laEspriella, Enrique Santas, Eduardo Núñez, Vicent Bodí, Francisco Javier Chorro, Alberto Cordero, Juan Sanchis, Josep Lupón, Antoni Bayés‐Genís, Julio Núñez
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3320-3328 (2020)
Abstract Aims Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and is related with worse outcomes. Insulin treatment is associated with sodium and water retention, weight gain, and hypoglycaemia—all pathophysiological m
Externí odkaz:
https://doaj.org/article/fcdcda27921c4489a1d003e180d32b61
Autor:
Gema Miñana, Julio Núñez, Antoni Bayés‐Genís, Elena Revuelta‐López, César Ríos‐Navarro, Eduardo Núñez, Francisco J. Chorro, Maria Pilar López‐Lereu, Jose Vicente Monmeneu, Josep Lupón, Juan Sanchis, Vicent Bodí
Publikováno v:
ESC Heart Failure, Vol 7, Iss 1, Pp 118-123 (2020)
Abstract Aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a therapeutic target for reducing plasma low‐density lipoprotein cholesterol. Beyond lipid control, recent findings suggest a deleterious effect of this protein in t
Externí odkaz:
https://doaj.org/article/cedec5d271054635af5751bf32f61fc5
Autor:
MIGUEL Lorenzo, GEMA MIÑANA, PATRICIA PALAU, MARTINA AMIGUET, JULIA SELLER, JOSE MANUEL GARCIA PINILLA, ELOY DOMÍNGUEZ, SANDRA VILLAR, RAFAEL DE LA ESPRIELLA, EDUARDO NÚÑEZ, JOSE LUIS GÓRRIZ, ALFONSO VALLE, VICENT BODÍ, JUAN SANCHIS, ANTONI BAYÉS-GENIS, JULIO NÚÑEZ
Publikováno v:
Journal of Cardiac Failure. 29:849-854
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5307a149cced987b6bb69b5a796d8d72
https://doi.org/10.1016/j.cardfail.2023.02.008
https://doi.org/10.1016/j.cardfail.2023.02.008
Autor:
Julio Núñez, Gema Miñana, Ingrid Cardells, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Luis Almenar, Maria P. López‐Lereu, Jose V. Monmeneu, Martina Amiguet, Jessika González, Alicia Serrano, Vicente Montagud, Raquel López‐Vilella, Ernesto Valero, Sergio García‐Blas, Vicent Bodí, Rafael de la Espriella‐Juan, Josep Lupón, Jorge Navarro, José Luis Górriz, Juan Sanchis, Francisco J. Chorro, Josep Comín‐Colet, Antoni Bayés‐Genís
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 4 (2020)
Background Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The aim of this study was to examin
Externí odkaz:
https://doaj.org/article/e1e8273a4ca540c59dcf92120389f24a